MA
Mankind Pharma Limited
MANKIND.NS · NSE
₹2,327.90 -1.73% (-₹40.90)
1M -5.22%
Market Cap ₹975.8B
P/E Ratio 47.77x
Div. Yield -
ROE 12.83%
Bulios Fair Price
₹2,527
8.6% upside
Trenutna cena
₹2,328
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MANKIND.NS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
6 /100
Expensive P/B 5.89x
P/S 6.62x
P/E 47.77x
Growth
82 /100
Growing Rev. growth 16.19%
Book val. growth 32.54%
EPS growth 11.12%
Profitability
80 /100
Strong FCF margin 9.27%
Op. margin 19.91%
Gross margin 50.75%
Quality
59 /100
Average ROE 12.83%
ROA N/A
Asset turnover N/A
Debt
90 /100
Low Int. coverage 5.42x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
80 /100
Stable Profitable years 6
EPS volatility 31.23%
Beta 0.45x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MANKIND.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sheetal Arora
Employees
20,451
Headquarters
New Delhi
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report